Siblings 圖書 [0/1] 會議論文/會議摘要 [13/20] Collection Statistics 近3年內發表的文件:10(17.24%) 含全文筆數:56(96.55%) 文件下載次數統計 下載大於0次:56(100.00%) 下載大於100次:51(91.07%) 檔案下載總次數:23508(79.16%) 最後更新時間: 2024-12-01 08:31 Top Upload Loading... Top Download Loading... Recent Submissions Delayed diagnosis of tuberous scler... CXCR7 activation evokes the anti-PD... Surgical excision and radiotherapy ... Neutralizing IL-16 enhances the eff... Role of SH3GLB1 in the regulation o... The complex role of eicosanoids in ... A novel combination therapy of argi... Role of autophagy in therapeutic re... SH3GLB1-related autophagy mediates ... Reprogramming of arachidonate metab...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 26-50 of 58. (3 Page(s) Totally) << < 1 2 3 > >> View [10|25|50] records per page

Date	Title	Relation
2017-10	Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis via up-regulation of fibronectin	FASEB Journal. 2017 Oct;31(10):4265-4276.
2017-08-12	Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase	Redox Biology. 2017 Aug 12;13:655-664.
2017-05-22	Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma	Oncogenesis. 2017 May 22;6(5):Article number e339.
2017-05	A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy	Journal of Clinical Oncology. 2017 May;35(Suppl. 15):Meeting Abstract 2531.
2016-11-18	Suberoylanilide hydroxamic acid represses glioma stem-like cells	Journal of Biomedical Science. 2016 Nov 18;23:Article number 81.
2016-07-19	MicroRNA-17 modulates regulatory T cell function by targeting co-regulators of the foxp3 transcription factor	Immunity. 2016 Jul 19;45(1):83-93.
2015-09	O6-Methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma	International Journal of Cancer. 2015 Sep;137(6):1291-1305.
2015-05	Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin beta1/FAK axis	Oncotarget. 2015 May;6(13):11530-11546.
2015-03	Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer	Oral Diseases. 2015 Mar;21(2):207-215.
2014-12-22	Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation	Oncotarget. 2014 Dec 22;6(3):1723-1739.
2014-11	The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer	International Journal of Cancer. 2014 Nov;135(10):2424-2436.
2014-10-24	Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5year follow-up	BMC Cancer. 2014 Oct 24;14:Article number 787.
2014-08	AMACR overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Tumor Biology. 2014 Aug;35(8):7983-7991.
2014-07	Cyclin-dependent kinase 4 overexpression is mostly independent of gene amplification and constitutes an independent prognosticator for nasopharyngeal carcinoma	Tumor Biology. 2014 Jul;35(7):7209-7216.
2014-05-05	Tea consumption and risk of head and neck cancer	PLoS ONE. 2014 May 5;9(5):Article number e96507.
2014-02	Fibronectin overexpression is associated with latent membrane protein 1 expression and has independent prognostic value for nasopharyngeal carcinoma	Tumor Biology. 2014 Feb;35(2):1703-1712.
2014-01	TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Tumor Biology. 2014 Jan;35(1):179-187.
2013-10	Investigating the association between oral hygiene and head and neck cancer	Oral Oncology. 2013 Oct;49(10):1010-1017.
2013-07	Bcl-6 expression and lactate dehydrogenase level predict prognosis of primary gastric diffuse large B-cell lymphoma	Journal of the Formosan Medical Association. 2013 Jul;112(7):382-389.
2013-06-27	Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance	Journal of Biomedical Science. 2013 Jun 27;20(1):Article number 43.
2013-05	Complete microscale profiling of tumor microangiogenesis: A microradiological methodology reveals fundamental aspects of tumor angiogenesis and yields an array of quantitative parameters for its characterization	Biotechnology Advances. 2013 May;31(3):396-401.
2013-03	Uropathogenic Escherichia coli causes cortical tubular necrotic cell death and the release of macrophage migration inhibitory factor	Cytokine. 2013 Mar;61(3):945-952.
2013-02-01	Allergies and risk of head and neck cancer: An original study plus meta-analysis	PLoS ONE. 2013 Feb 1;8(2):Article number e55138.
2012-07-27	Hepatitis B virus X protein upregulates mTOR signaling through IKKBeta to increase cell proliferation and VEGF production in hepatocellular carcinoma	PLoS ONE. 2012 Jul 27;7(7):Article number e41931.
2011-11-15	Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo	Clinical Cancer Research. 2011 Nov 15;17(22):7116-7126.

Showing items 26-50 of 58. (3 Page(s) Totally) << < 1 2 3 > >> View [10|25|50] records per page